Cardiac rehabilitation for cardiac syndrome X and microvascular angina: A case report
|
|
|
- Rafe Dorsey
- 10 years ago
- Views:
Transcription
1 case REPORT PEER REVIEWED OPEN ACCESS Cardiac rehabilitation for cardiac syndrome X and microvascular angina: A case report Wipawee Laksanakorn, Tanaporn Laprattanagul, Janet Wei, Chrisandra Shufelt, Margo Minissian, Puja K. Mehta, C. Noel Bairey Merz ABSTRACT Introduction: Therapeutic strategies for cardiac syndrome X, characterized by the three features of angina, evidence of myocardial ischemia and no obstructive coronary artery disease, are not well known. Recent data indicate that angina secondary to microvascular coronary dysfunction is a common pathogenesis of cardiac syndrome X. While cardiac rehabilitation is well-known to be effective for angina due to obstructive coronary artery disease, less is known in cardiac syndrome X and microvascular angina patients. Case Report: A 34-year-old female with history of pre-eclampsia during three pregnancies, recurrent non-st-segment-elevation myocardial infarctions, no obstructive coronary artery disease, microvascular coronary dysfunction documented by coronary reactivity testing, ischemic cardiomyopathy, overweight, factor V Leiden mutation, and persistent microvascular angina was referred to cardiac rehabilitation five weeks after a non-st-segment-elevation myocardial infarction. The patient was taking a beta blocker, ACE, statin and low dose aspirin. She underwent four sessions of supervised cardiac rehabilitation program which progressed to a duration of 45 minutes at a level of 3.3 metabolic equivalents of aerobic exercise. A normal cardiovascular response without arrhythmias was observed. A home program was suggested with moderate intensity of aerobic exercise, minutes per day, most days of the week. She experienced decreased angina, improved quality of life and increased functional capacity at the fourth-year of follow-up. Conclusion: Cardiac rehabilitation was beneficial in the patient angina due to microvascular coronary dysfunction. Increased exercise intensity and duration, increased functional capacity, decreased anginal symptoms and improved quality of life were found. International Journal of Case Reports and Images (IJCRI) International Journal of Case Reports and Images (IJCRI) is an international, peer reviewed, monthly, open access, online journal, publishing high-quality, articles in all areas of basic medical sciences and clinical specialties. Aim of IJCRI is to encourage the publication of new information by providing a platform for reporting of unique, unusual and rare cases which enhance understanding of disease process, its diagnosis, management and clinico-pathologic correlations. IJCRI publishes Review Articles, Case Series, Case Reports, Case in Images, Clinical Images and Letters to Editor. Website: (This page in not part of the published article.)
2 Laksanakorn et al. 239 CASE case REPORT report Peer Reviewed OPEN ACCESS Cardiac rehabilitation for cardiac syndrome X and microvascular angina: A case report Wipawee Laksanakorn, Tanaporn Laprattanagul, Janet Wei, Chrisandra Shufelt, Margo Minissian, Puja K. Mehta, C. Noel Bairey Merz Abstract Introduction: Therapeutic strategies for cardiac syndrome X, characterized by the three features of angina, evidence of myocardial ischemia and no obstructive coronary artery disease, are not well known. Recent data indicate that angina secondary to microvascular coronary dysfunction is a common pathogenesis of cardiac syndrome X. While cardiac rehabilitation is well-known to be effective for angina due to obstructive coronary artery disease, less is known in cardiac syndrome X and microvascular angina patients. Case Report: A 34-year-old female with history of pre-eclampsia during three pregnancies, Wipawee Laksanakorn 1, Tanaporn Laprattanagul 1, Janet Wei 2, Chrisandra Shufelt 3, Margo Minissian 4, Puja K Mehta 5, C. Noel Bairey Merz 6 Affiliations: 1 MD, Rehabilitation Department, Golden Jubilee Medical Center, NakhonPathom, Thailand; 2 MD, FACC, Barbra Streisand Women s Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; 3 MD, MS, FACP, Associate Director, Barbra Streisand Women s Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; 4 Ph.Dc, ACNP, FACC, Cardiology Nurse Practitioner, Barbra Streisand Women s Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States; 5 MD, FACC, Director, Non- Invasive Vascular Function Research Lab, Barbra Streisand Women s Heart Center, Cedars-Sinai Heart Institute, Cedars- Sinai Medical Center, Los Angeles, CA, United States; 6 MD, FACC, FAHA, Director, Barbra Streisand Women s Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States. Corresponding Author: C. Noel Bairey Merz, MD, FACC, FAHA, 127 South San Vicente Boulevard, Suite A3206, Los Angeles, CA, 90048, United States; Ph: , Fax: ; [email protected] Received: 27 November 2014 Accepted: 15 January 2015 Published: 01 April 2015 recurrent non-st-segment-elevation myocardial infarctions, no obstructive coronary artery disease, microvascular coronary dysfunction documented by coronary reactivity testing, ischemic cardiomyopathy, overweight, factor V Leiden mutation, and persistent microvascular angina was referred to cardiac rehabilitation five weeks after a non-st-segment-elevation myocardial infarction. The patient was taking a beta blocker, ACE, statin and low dose aspirin. She underwent four sessions of supervised cardiac rehabilitation program which progressed to a duration of 45 minutes at a level of 3.3 metabolic equivalents of aerobic exercise. A normal cardiovascular response without arrhythmias was observed. A home program was suggested with moderate intensity of aerobic exercise, minutes per day, most days of the week. She experienced decreased angina, improved quality of life and increased functional capacity at the fourth-year of follow-up. Conclusion: Cardiac rehabilitation was beneficial in the patient angina due to microvascular coronary dysfunction. Increased exercise intensity and duration, increased functional capacity, decreased anginal symptoms and improved quality of life were found. Keywords: Cardiac rehabilitation, Cardiac syndrome X, Exercise training, Microvascular angina, Microvascular coronary dysfunction How to cite this article Laksanakorn W, Laprattanagul T, Wei J, Shufelt C, Minissian M, Mehta PK, Merz CNB. Cardiac rehabilitation for cardiac syndrome X and microvascular angina: A case report. Int J Case Rep Images 2015;6(4): doi: /ijcri cr-10503
3 INTRODUCTION Therapeutic strategies for cardiac syndrome X (CSX), characterized by three features, including angina, evidence of myocardial ischemia on stress testing, and no obstructive coronary artery disease (CAD) are not well known. Data from the National Heart, Lung and Blood Institute-sponsored Women s Ischemia Syndrome Evaluation (NHLBI-WISE) study demonstrates that microvascular coronary dysfunction (MCD) is present in approximately half of women with CSX [1]. In addition, prognosis for patients with CSX may not be as benign as previously thought especially in patients with evidence of microvascular coronary dysfunction. The NHLBI-WISE study demonstrated a five-year cardiovascular event rate of 16% for women with non-obstructive CAD and 7.9% for women with normal coronary arteries, compared to 2.4% for asymptomatic women with no history of heart disease [2]. Nevertheless the contributing pathogenesis of angina in CSX remains controversial. Possible mechanisms for the angina have been reported, including myocardial ischemia due to microvascular and endothelial coronary dysfunction, and abnormal cardiac pain perception [3]. While there is wide acceptance of the benefits of cardiac rehabilitation (CR) for patients with obstructive CAD [4], CR is underutilized with the approximate mean referral rate of 34%. Among CAD patients eligible for CR, participation rates for women are lower than men in most studies [5]. Furthermore, there are few studies evaluating impact of CR on CSX patients and microvascular angina patients. In this report, the case of woman with microvascular angina is examined to highlight the potential benefit of CR in this group of patients. Laksanakorn et al. 240 abnormal at 22% constriction (normal is dilation >0%), and nitroglycerin response was normal at 46% dilation (normal >20%) as depicted in Figures 1 and 2. Resting echocardiogram in 2005 demonstrated a left ventricular ejection fraction (LVEF) of 55% with basal to mid-septal hypokinesis. From , she had a total of NSTEMI admissions with elevated cardiac troponin I ranging between 0.1 ng/ml in 2008 and 33 ng/ml in Resting echocardiogram in 2007 demonstrated basal to mid-inferior wall akinesis with hypokinesis of inferolateral wall and interventricular septum with an LVEF of 35 45%. Myocardial biopsy revealed focal fibrosis without vasculitis or inflammation. During the NSTEMI admission prior to CR referral, she had substernal and left sided chest pain which woke her up from sleep. Normal sinus rhythm with inferolateral T wave inversions was shown on ECG, accompanied by an elevated troponin I to 1.72 ng/ml. A diagnosis of ischemic cardiomyopathy and microvascular angina secondary to coronary microvascular dysfunction was made. At the time of cardiac rehabilitation referral in 2008, cardiovascular risk factor profile revealed a body mass index of 26.3 (overweight), no diabetes, no dyslipidemia, no history of smoking and no family history of premature CAD. She experienced fatigue during ordinary daily CASE REPORT A 34-year-old female was referred to cardiac rehabilitation five weeks after a non-st-segment-elevation myocardial infarction (NSTEMI) in She had a prior history of pre-eclampsia with three pregnancies and was heterozygous for factor V Leiden mutation. She had a history of NSTEMI with no obstructive CAD in 2005 and had persistent exertional and non-exertional episodes of angina. She had multiple emergency department visits for angina. She was diagnosed with MCD by invasive coronary reactivity testing using intra-coronary adenosine and acetylcholine [6] in MCD was diagnosed by invasive coronary reactivity testing as previously published (Figure 1) [6]. She had normal coronary arteriography without luminal irregularity and left ventricular end-diastolic filling pressure was elevated at 17 mmhg. Coronary flow reserve (CFR) in response to adenosine (Figure 2) was abnormal at 1.9 (normal >2.5), coronary blood flow response to acetylcholine was mildly abnormal at 48% increase (normal is 50% increase), coronary artery diameter dilation response to acetylcholine was markedly Figure 1: Coronary angiogram and coronary reactivity testing. Coronary reactivity testing is performed with a Doppler wire in the left anterior descending artery. Intracoronary acetylcholine infusion produced vasoconstriction (arrow) of the artery compared to baseline (normal response is dilation), and intracoronary nitroglycerin infusion subsequently dilated the artery with a normal response. Acetylcholine tests endothelialdependent macrovascular and microvascular function. Figure 2: Intracoronary Doppler blood flow velocity waveforms in response to intracoronary adenosine. Coronary flow reserve is the ratio of average peak velocities before and after adenosine administration. Adenosine tests nonendothelial-dependent microvascular function.
4 activity and shortness of breath during moderate to strenuous physical activity. She did not exercise regularly and had exertional and stress-related angina. No symptoms and signs of heart failure were found. Previously, she was a school teacher and practiced figure skating a few times per week. She was unemployed at the time of CR referral. A Duke Activity Status Index (DASI) questionnaire score was 15.2 corresponding to 4.3 metabolic equivalents (METs) [7]. A general quality of life (QOL) rating was 3 in answer to the question Overall, how would the patient rate her QOL? The possible responses fall along an interval scale from 0 (worst) to 10 (best). During CR, the patient initially had resting blood pressure (BP) of 92/60 mmhg and heart rate (HR) of 86 beats per minute (bpm). Her physical examination was unremarkable. Her CR plan included reconditioning exercises three times a week for 12 weeks, including aerobic and strengthening exercises, as well as nutritional counseling and stress management. She exercised to 2.1 METs for 35 minutes using treadmill and stationary cycling in the first session. Peak HR rose to 1 bpm, BP was 0/62 mmhg and the rating of perceived exertion (RPE) was. No arrhythmia on ECG telemetry was noted and no abnormal symptoms were reported. Due to conflicts with childcare, she only attended four CR sessions (Table 1). She increased her exercise tolerance to 45 minutes of treadmill and cycling with the intensity of 3.3 METs. A home CR program with moderate intensity of aerobic exercise such as brisk walk, minutes per day for most days of the week was advised because she could not return to a supervised program. The patient was treated medically with aspirin, dabigatran, metoprolol, ramipril, atorvastatin, nitroglycerin transdermal patch and acetaminophencodeine as needed for pain. In 2012, she underwent implantable cardioverter-defibrillator placement due to a declined LVEF to 30%. Subsequently, her symptoms were improved, and she continued walking exercise at Laksanakorn et al. 241 home. At four-year follow-up, she reported decreased anginal symptoms, improved overall health status, improved functional capacity demonstrated by a DASI questionnaire score of (7.7 METs) and a general QOL rating of 5/10. DISCUSSION The patient had the general characteristic features of CSX, including angina, evidence of myocardial ischemia and no obstructive CAD by coronary angiography. These findings along with further evaluation and abnormal coronary reactivity testing indicated the specific diagnosis of ischemic cardiomyopathy with microvascular angina secondary to CMD. She was able to increase exercise intensity from 2.1 to 3.3 METs after four sessions of CR program without abnormal chest pain and arrhythmia. While the exercise duration was optimal at minutes, low exercise intensity and poor functional capacity were observed. Ideally, a supervised CR program should have been continued but she could not complete a full program of 36 sessions. Home CR program played a key role in this patient, including aerobic exercise, strengthening exercise, stress management technique and healthy heart diet intake. As a multifaceted structured program that encourages exercise, education, nutrition counseling and psychosocial intervention, CR provides a therapeutic opportunity in CSX and microvascular angina patients (Figure 3) [8]. Eriksson et al revealed that there was improvement in exercise capacity by 34%, delayed onset of chest pain during exercise by 100% and tendency to increased endothelium-dependent blood flow in CSX after eight weeks of aerobic exercise [9]. Moreover, the eight-week CR program was shown to modify cardiovascular risk factors, including lower resting diastolic blood pressure and body mass index, improved physical fitness from Shuttle Walk Test performance, reduced symptom Table 1: Exercise record. Mode Intensity Duration (min) Session 1 - Treadmill - Bike Session 2 - Treadmill - Bike Session 3 - Treadmill - Elliptical Session 4 - Treadmill - Bike Speed 1.5 Grade 0% Level 1 Speed 3 Grade 0% Level 1 Speed 3 Grade 0 % Level 1 Speed 3 Grade 0% Level METs HR Range (bpm) BP Range (mmhg) RPE Resting HR Resting HR Resting HR Resting HR Resting BP 92/60 106/60 0/62 Resting BP 100/58 2/60 120/60 Resting BP 94/40 0/58 6/60 Resting BP 98/60 6/60 8/58 Abbreviations: min=minutes, MET=metabolic equivalent, HR=heart rate, bpm=beats per minute, BP=blood pressure, mmhg=millimeters mercury, RPE=rating of perceived exertion
5 Laksanakorn et al. 242 Figure 3: Model of microvascular disease in women. Reprinted with permission from Daniels KM et al. [8]. severity and improved QOL in CSX patients [10]. In microvascular angina patients, Carvalho et al. reported a case with improved endothelium-dependent vasodilator response of brachial artery, reversal of the ischemic myocardial perfusion defect from single-photon emission computed tomography, improved angina symptoms and QOL after the four-month aerobic training []. Our report showed the benefits of CR, including increased exercise intensity, exercise duration, improved functional capacity and decreased anginal symptoms in this patient with proven microvascular angina. Women with CSX often have impaired functional capacity and/or are deconditioned. The DASI is a 12- item self-reported questionnaire that captures functional capacity. The DASI score is validated to estimate maximal oxygen consumption from exercise stress test. By dividing the DASI score by 3.5, METs are derived. The application of DASI might be used instead of exercise stress test to identify at-risk symptomatic women, predict prognosis and target risk management. Among symptomatic women with suspected myocardial ischemia from the NHLBI-WISE study, functional impairment measured by the exercise stress test and DASI-estimated METs 4.7 correlated with an adverse prognosis, including higher death and nonfatal myocardial infarction rates [7]. Notably, even small increases in functional capacity after CR participation could reduce cardiovascular mortality and morbidity. In a retrospective review in women referred for stress testing, for every MET increase in exercise capacity, there was a 25% reduction in the rate of all-cause death [12]. Our patient also reported functional capacity improvement, demonstrated by 3.4 METs increase of DASI score at the fourth-year of follow-up, which suggests better prognosis. In terms of QOL, the eight-week CR program improved QOL scales in women with CSX based on a SF-36 questionnaire [10, 13]. Similarly, a slight increase of a general QOL rating scale and improved overall health status was reported in our patient at the four-year follow-up. Although CR is recommended for all patients with CAD and chronic angina, participation rate is low especially in women [14]. Women are faced with several barriers to CR attendance, including caregiving responsibilities observed in our patient. Referral of women to CR should be strongly considered by physicians, as it positively affects physical and psychological outcomes in patients with CSX, MCD and microvascular angina. CONCLUSION This report suggests that cardiac rehabilitation was beneficial in a patient with cardiac syndrome X, cardiac syndrome X, diagnosed with ischemic cardiomyopathy and microvascular angina secondary to microvascular coronary dysfunction. Even though the patient did not complete the cardiac rehabilitation (CR) session plan, CR increased her exercise intensity and duration, improved functional capacity, decreased anginal symptoms and improved quality of life. *********
6 Author Contributions Wipawee Laksanakorn Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Tanaporn Laprattanagul Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Janet Wei Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Chrisandra Shufelt Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Margo Minissian Acquisition of data, Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Puja K. Mehta Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published C. Noel Bairey Merz Substantial contributions to conception and design, Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published Guarantor The corresponding author is the guarantor of submission. Conflict of Interest Authors declare no conflict of interest. Copyright 2015 Wipawee Laksanakorn et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information. REFERENCES 1. Reis SE, Holubkov R, Conrad Smith AJ, et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study. Am Heart J 2001 May;141(5): Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: A report from the Women s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009 May ;169(9): Laksanakorn et al Cannon RO 3rd. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol 2009 Sep 1;54(10): Taylor RS, Brown A, Ebrahim S, et al. Exercisebased rehabilitation for patients with coronary heart disease: Systematic review and meta-analysis of randomized controlled trials. Am J Med 2004 May 15;6(10): Cortes O, Arthur HM. Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: A systematic review. Am Heart J 2006 Feb;151(2): Wei J, Mehta PK, Johnson BD, et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: Results from the NHLBIsponsored WISE (Women s Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv 2012 Jun;5(6): Shaw LJ, Olson MB, Kip K, et al. The value of estimated functional capacity in estimating outcome: Results from the NHBLI-Sponsored Women s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006 Feb 7;47(3 Suppl):S Daniels KM, Arena R, Lavie CJ, Forman DE. Cardiac rehabilitation for women across the lifespan. Am J Med 2012 Sep;125(9):937.e Eriksson BE, Tyni-Lennè R, Svedenhag J, et al. Physical training in Syndrome X: Physical training counteracts deconditioning and pain in Syndrome X. J Am Coll Cardiol 2000 Nov 1;36(5): Asbury EA, Slattery C, Grant A, Evans L, Barbir M, Collins P. Cardiac rehabilitation for the treatment of women with chest pain and normal coronary arteries. Menopause 2008 May-Jun;15(3): Carvalho EE, Crescêncio JC, Elias J Jr, Brito LB, Gallo L Jr, Simões MV. Improved endothelial function and reversal of myocardial perfusion defects after aerobic physical training in a patient with microvascular myocardial ischemia. Am J Phys Med Rehabil 20 Jan;90(1): Fletcher GF, Ades PA, Kligfield P, et al. Exercise Standards for Testing and Training: A Scientific Statement From the American Heart Association. Circulation 2013 Aug 20;128(8): Feizi A, Ghaderi C, Dehghani MR, Khalkhali HR, Sheikhi S. Effect of phase III cardiac rehabilitation and relaxation on the quality of life in patients with cardiac syndrome X. Iran J Nurs Midwifery Res 2012 Nov;17(7): Montalescot G, Sechtem U, Achenbach S, et al ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013 Oct;34(38): Suggested Reading Agrawal S, Mehta P, Bairey-Merz CN. Cardiac Syndrome X: Update Cardiology Clinics (2014) doi / /j.ccl
7 Crea F, Camici PG, BaireyMerz CN. Coronary Microvascular Dysfunction: An update. Eur Heart J May;35(17):01-. Laksanakorn et al. 244 BaireyMerz CN, Pepine CJ. Syndrome X and Microvascular Coronary Dysfunction. Circulation 20;124: Access full text article on other devices Access PDF of article on other devices
8 Edorium Journals Edorium Journals et al. EDORIUM JOURNALS AN INTRODUCTION Edorium Journals: An introduction Edorium Journals Team About Edorium Journals Edorium Journals is a publisher of high-quality, open access, international scholarly journals covering subjects in basic sciences and clinical specialties and subspecialties. Invitation for article submission We sincerely invite you to submit your valuable research for publication to Edorium Journals. But why should you publish with Edorium Journals? In less than 10 words - we give you what no one does. Vision of being the best We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day of every week of every month of every year. Exceptional services We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this. Editorial Review All manuscripts submitted to Edorium Journals undergo pre-processing review, first editorial review, peer review, second editorial review and finally third editorial review. Peer Review All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review. Our Commitment Six weeks You will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this by even one day, we will publish your manuscript free of charge. Four weeks After we receive page proofs, your manuscript will be published in the journal within four weeks (31 days). If we fail to honor this by even one day, we will publish your manuscript free of charge and refund you the full article publication charges you paid for your manuscript. Mentored Review Articles (MRA) Our academic program Mentored Review Article (MRA) gives you a unique opportunity to publish papers under mentorship of international faculty. These articles are published free of charges. Favored Author program One is all it takes to become our favored author. You will not only get fee waivers but also get information and insights about scholarly publishing. Institutional Membership program Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in fees make their research accessible to all. Early View version Early View version of your manuscript will be published in the journal within 72 hours of final acceptance. Manuscript status From submission to publication of your article you will get regular updates (minimum six times) about status of your manuscripts directly in your . Our presence We have some of the best designed publication formats. Our websites are very user friendly and enable you to do your work very easily with no hassle. Something more... We request you to have a look at our website to know more about us and our services. We welcome you to interact with us, share with us, join us and of course publish with us. CONNECT WITH US Edorium Journals: On Web Browse Journals This page is not a part of the published article. This page is an introduction to Edorium Journals and the publication services.
Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone
James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest
The Canadian Association of Cardiac
Reinventing Cardiac Rehabilitation Outside of acute care institutions, cardiovascular disease is a chronic, inflammatory process; the reduction or elimination of recurrent acute coronary syndromes is a
6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology
Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die
Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better
Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.
Section 8: Clinical Exercise Testing. a maximal GXT?
Section 8: Clinical Exercise Testing Maximal GXT ACSM Guidelines: Chapter 5 ACSM Manual: Chapter 8 HPHE 4450 Dr. Cheatham Outline What is the purpose of a maximal GXT? Who should have a maximal GXT (and
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
7th annual ConFerenCe location
Sponsors 7th Annual WOMEN and Ischemic Heart Disease Symposium Friday, April 19, 2013 Offered in cooperation with the California Chapter of the American College of Cardiology and WomenHeart: The National
123 Main St NY, New York 12345 ph: (202) 555 5555 fax: (202) 555 5555
Patient Name: DOE, JOHN D. Gender: M Date of Study: 4/2/2013 Date of birth: 6/28/1962 Age: 50 Medical Record #: 45869725 Ordering Physician: JANE INTERNIST, MD History: Atypical Angina, Abn ECG, High Cholesterol,
2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.
DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart
Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology
Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of
Main Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
Listen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1
Post CABG Rehabilitation i Ahmed Elkerdany Professor of Cardiac Surgery Ain Shams University 1 Definition Cardiac rehabilitation services are comprehensive, long-term programs involving : medical evaluation.
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts
Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.
Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy
Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:
Protocol. Cardiac Rehabilitation in the Outpatient Setting
Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,
GENERAL HEART DISEASE KNOW THE FACTS
GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to
Utilization Review Cardiac Rehabilitation Services: Underutilized
Utilization Review Cardiac Rehabilitation Services: Underutilized William J. Gill, MD Krannert Institute of Cardiology Indiana University School of Medicine Indianapolis, Indiana What is Cardiac Rehab?
Efficient Evaluation of Chest Pain
Efficient Evaluation of Chest Pain Vikranth Gongidi, DO FACC FACOI Indian River Medical Center Vero Beach, FL No Disclosures Outline Background Chest pain pathway Indications for stress test Stress test
Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease
Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification
Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine
Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of
Cardiac Rehabilitation: Strategies Approaching 2020
ACC Banff 2015 Cardiac Rehabilitation: Strategies Approaching 2020 James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Libin Cardiovascular
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
The Copernican Revolution in Ischemic Heart Diseases: the day after
Menarini Foundation Symposia: 249 The Copernican Revolution in Ischemic Heart Diseases: the day after Pisa (Italy), June 27 th 28 th, 2014 Organized by POSTGRADUATE SCHOOL OF CARDIOVASCULAR MEDICINE UNIVERSITY
MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging. Anne Günther Department of Radiology OUS Rikshospitalet
MYOCARDIAL PERFUSION COMPUTED TOMOGRAPHY PhD course in Medical Imaging Anne Günther Department of Radiology OUS Rikshospitalet CORONARY CT ANGIOGRAPHY (CTA) Accurate method in the assessment of possible
Automatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC The Federal Motor Carrier Safety Administration (FMCSA) administers the Federal Motor Carrier Safety Regulations (FMCSRs)
Vascular Effects of Caffeine
Vascular Effects of Caffeine John P. Higgins MD, MBA, MPHIL, FACC, FACP, FAHA, FACSM, FASNC, FSGC Director of Exercise Physiology Memorial Hermann Sports Medicine Institute Chief of Cardiology, Lyndon
Understanding the Pain Trajectory During Treadmill Testing in Peripheral Artery Disease
Understanding the Pain Trajectory During Treadmill Testing in Peripheral Artery Disease Diane Treat-Jacobson, PhD, RN, FAHA, FAAN Susan J. Henly, PhD, RN Ulf G. Bronas, PhD, ATC, ATR Arthur S. Leon, MD,
DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
Cardiac Rehabilitation at AUBMC
Cardiac Rehabilitation at AUBMC Clinical Protocols and The Role of The Advanced Practice Nurse Presentation by: Mohamad Issa, MSN, BSN, BC- RN, AUBMC CCU OUTLINE Background on cardiovascular diseases History
How do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
Stress is linked to exaggerated cardiovascular reactivity. 1) Stress 2) Hostility 3) Social Support. Evidence of association between these
Psychosocial Factors & CHD Health Psychology Psychosocial Factors 1) Stress 2) Hostility 3) Social Support Evidence of association between these psychosocial factors and CHD Physiological Mechanisms Stress
Electrocardiographic Issues in Williams Syndrome
Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital
URN: Family name: Given name(s): Address:
State of Queensland (Queensland Health) 2015 Licensed under: http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Contact: [email protected] Facility:... Clinical pathways
How should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
Osama Jarkas. in Chest Pain Patients. STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015
STUDENT NAME: Osama Jarkas DATE: August 10 th, 2015 PROJECT TITLE: Analysis of ECG Exercise Stress Testing and Framingham Risk Score in Chest Pain Patients PRIMARY SUPERVISOR NAME: Dr. Edward Tan DEPARTMENT:
INTRODUCTION TO EECP THERAPY
INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and
ECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION. POLICY NUMBER: 8.01.14 CATEGORY: Therapy/ Rehabilitation
MEDICAL POLICY SUBJECT: CARDIAC REHABILITATION PAGE: 1 OF: 6 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators
Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators Shaikha Al Naimi Doctor of Pharmacy Student College of Pharmacy Qatar University
Tackling the Semantic Interoperability challenge
European Patient Summaries: What is next? Tackling the Semantic Interoperability challenge Dipak Kalra Cross-border health care The context for sharing health summaries Also useful for within-border health
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
Heart Failure & Cardiac Rehabilitation
Heart Failure & Cardiac Rehabilitation Karen Lui, RN, MS, MAACVPR SCACVPR Greenville May 3, 2014 1 I have no disclosures. 2 Outline New Professional Certification New AACVPR CR Guidelines New Heart Failure
Cardiac Rehabilitation CARDIAC REHABILITATION HS-091. Policy Number: HS-091. Original Effective Date: 3/16/2009
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. M issouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
The Department of Vermont Health Access Medical Policy
State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 [Phone] 802-879-5903 Williston, VT 05495-2807 [Fax] 802-879-5963 www.dvha.vermont.gov Agency of Human Services The Department
Remote Delivery of Cardiac Rehabilitation
Remote Delivery of Cardiac Rehabilitation Bonnie Wakefield, RN, PhD Kariann Drwal, MS Melody Scherubel, RN Thomas Klobucar, PhD Skyler Johnson, MS Peter Kaboli, MD, MS VA Rural Health Resource Center Central
KIH Cardiac Rehabilitation Program
KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 [email protected] What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to
Atrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
on behalf of the AUGMENT-HF Investigators
One Year Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure* Douglas
RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department
RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital
Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
Addendum to Clinical Review for NDA 22-512
Addendum to Clinical Review for DA 22-512 Drug: Sponsor: Indication: Division: Reviewers: dabigatran (Pradaxa) Boehringer Ingelheim Prevention of stroke and systemic embolism in atrial fibrillation Division
2013 ACO Quality Measures
ACO 1-7 Patient Satisfaction Survey Consumer Assessment of HealthCare Providers Survey (CAHPS) 1. Getting Timely Care, Appointments, Information 2. How well Your Providers Communicate 3. Patient Rating
Prognostic impact of uric acid in patients with stable coronary artery disease
Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,
Diagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
CASE B1. Newly Diagnosed T2DM in Patient with Prior MI
Newly Diagnosed T2DM in Patient with Prior MI 1 Our case involves a gentleman with acute myocardial infarction who is newly discovered to have type 2 diabetes. 2 One question is whether anti-hyperglycemic
What is a Heart Attack? 1,2,3
S What is a Heart Attack? 1,2,3 Heart attacks, otherwise known as myocardial infarctions, are caused when the blood supply to a section of the heart is suddenly disrupted. Without the oxygen supplied by
Heart Attack: What You Need to Know
A WorkLife4You Guide Heart Attack: What You Need to Know What is a Heart Attack? The heart works 24 hours a day, pumping oxygen and nutrient-rich blood to the body. Blood is supplied to the heart through
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know
Acute Coronary Syndrome What Every Healthcare Professional Needs To Know Background of ACS Acute Coronary Syndrome (ACS) is an umbrella term used to cover a spectrum of clinical conditions that are caused
2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:
The ACC 50 th Annual Scientific Session
Special Report The ACC 50 th Annual Scientific Session Part Two From March 18 to 21, 2001, physicians from around the world gathered to learn, to teach and to discuss at the American College of Cardiology
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI)
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf
Perioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
Success factors in Behavioral Medicine
Success factors in Behavioral Medicine interventions post myocardial infarction Depression Gunilla post myocardial Burell, PhD infarction Department of Public Health, Uppsala University, Sweden XIII Svenska
Redefining the NSTEACS pathway in London
Redefining the NSTEACS pathway in London Sotiris Antoniou Consultant Pharmacist, Cardiovascular Medicine, Barts and The London NHS Trust and Project Lead, North East London Cardiovascular and Stroke Network
IMGPT: Exercise After a Heart Attack 610 944 8140 805 N. RICHMOND ST (Located next to Fleetwood HS) Why is exercise important following a heart
Why is exercise important following a heart attack? Slow progression back into daily activity is important to strengthen the heart muscle and return blood flow to normal. By adding aerobic exercises, your
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis
Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis Methodology: 8 respondents The measures are incorporated into one of four sections: Highly
Outpatient/Ambulatory Rehab. Dedicated Trans-disciplinary Team (defined within Annotated References)
CARDIAC The delivery of Cardiac Rehab is unlike most other rehab populations. The vast majority of patients receive their rehab in outpatient or community settings and only a small subset requires an inpatient
Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart
The new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
INFORMED CONSENT INFORMED CONSENT FOR PARTICIPATION IN A HEALTH AND FITNESS TRAINING PROGRAM
INFORMED CONSENT INFORMED CONSENT FOR PARTICIPATION IN A HEALTH AND FITNESS TRAINING PROGRAM NAME: DATE: 1. PURPOSE AND EXPLANATION OF PROCEDURE I hereby consent to voluntarily engage in an acceptable
Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
Coronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
Ngaire has Palpitations
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
CARDIAC REHABILITATION Winnipeg Region Annual Report 2013-14
CARDIAC REHABILITATION Winnipeg Region Annual Report 2013-14 PROGRAM OVERVIEW The Cardiac Rehabilitation Program (CRP) operates out of two medical fitness facilities in Winnipeg, the Reh- Fit Centre and
Understanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
TASK FORCE SUPPLEMENT FOR FUNCTIONAL CAPACITY EVALUATION
TASK FORCE SUPPLEMENT FOR FUNCTIONAL CAPACITY EVALUATION A. GENERAL PRINCIPLES Use of a Functional Capacity Evaluation (FCE) is to determine the ability of a patient to safely function within a work environment.
38 year old female with mild obesity. She is planning an exercise program to loose weight. She has no other known risk factors for CAD.
Stress Testing: Wael A. Jaber, MD,FACC 38 year old female with mild obesity She is planning an exercise program to loose weight. She has no other known risk factors for CAD. You recommend: A. Exercise
Central Office N/A N/A
LCD ID Number L32688 LCD Title Cardiac Rehabilitation and Intensive Cardiac Rehabilitation Contractor s Determination Number L32688 AMA CPT/ADA CDT Copyright Statement CPT only copyright 2002-2011 American
Samir B. Pancholy, MD, FACC, FSCAI 570-840-9852
Samir B. Pancholy, MD, FACC, FSCAI 570-840-9852 Medical School: B.J. Medical College, Ahmedabad, India 6-1981 to 5-1987. Residency: State University of New York at Stony Brook, Stony Brook, NY, Internal
SOUTH EAST WALES CARDIAC NETWORK INTEGRATED CARE PATHWAY CARDIAC REHABILITATION MAY 2005
Name Address SOUTH EAST WALES CARDIAC NETWORK INTEGRATED CARE PATHWAY CARDIAC REHABILITATION MAY 2005 Ms / Miss / Mr / Mrs Addressograph Known as Telephone Number of Birth Hospital No. NHS No. Cardiac
New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine
New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine Disclosures & Relevant Relationships I have nothing to disclose No financial conflicts Editor,
Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013
Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation Michael Acker, MD For the CTSN Investigators AHA November 2013 Acknowledgements Supported by U01 HL088942 Cardiothoracic
Blood Pressure Assessment Program Screening Guidelines
Blood Pressure Assessment Program Screening Guidelines Assessment Pre-Assessment Prior to/during assessment, explain to client the following: What is meant by high blood pressure; What are the effects
HYPERTROPHIC CARDIOMYOPATHY
HYPERTROPHIC CARDIOMYOPATHY Most often diagnosed during infancy or adolescence, hypertrophic cardiomyopathy (HCM) is the second most common form of heart muscle disease, is usually genetically transmitted,
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy
How to control atrial fibrillation in 2013 The ideal patient for a rate control strategy L. Pison, MD Advances in Cardiac Arrhythmias and Great Innovations in Cardiology - Torino, September 28 th 2013
